The prime minister says news from Pfizer today that one of its vaccine candidates appears very effective in clinical trials is "very encouraging" but won't help anyone who catches the virus in the meantime.
Friday’s meeting follows months of skepticism about the drug, developed by Cambridge, Massachusetts-based Biogen Inc. and Japan’s Eisai Co.
Health Canada granted a medical device licence on Monday to a one-minute, finger-prick blood test manufactured by Richmond, B.C.-based bioLytical Laboratories.
The Patented Medicine Prices Review Board has released data showing cancer medications account for about 15 per cent of all spending on pharmaceuticals.
While overall, colon cancer rates have been declining, the draft guidelines issued Tuesday by the U.S. Preventive Services Task Force reflect a growing concern about rising rates in people under the age of 50.
There are two main arms of the immune system. Innate immunity is the body’s first line of defence.